NFKB1 and chronic obstructive pulmonary disease: Although NF-κB:DNA binding activity is reported to be increased in patients who smoke when compared to non-smoking patients, a difference in NF-κB pathway activity was not observed between “healthy” smokers and smokers with COPD [39].